Click here to get full coverage on TG Therapeutics (TGTX) Gains as Its Key Drug Exceeded Expectations - Yahoo Finance

TG Therapeutics (TGTX) Gains as Its Key Drug Exceeded Expectations  Yahoo Finance

TG Therapeutics (TGTX) Gains as Its Key Drug Exceeded Expectations - Yahoo Finance

Click here to get full coverage on Is TG Therapeutics (TGTX) Fully Valued Following Its New Schizophrenia Trial Launch? - simplywall.st

Is TG Therapeutics (TGTX) Fully Valued Following Its New Schizophrenia Trial Launch?  simplywall.st

Is TG Therapeutics (TGTX) Fully Valued Following Its New Schizophrenia Trial Launch? - simplywall.st

Click here to get full coverage on TGTX Maintained by HC Wainwright & Co. -- Price Target Raised to $77 - GuruFocus

TGTX Maintained by HC Wainwright & Co. -- Price Target Raised to $77  GuruFocus

TGTX Maintained by HC Wainwright & Co. -- Price Target Raised to $77 - GuruFocus

Click here to get full coverage on (TGTX) and the Role of Price-Sensitive Allocations - Stock Traders Daily

(TGTX) and the Role of Price-Sensitive Allocations  Stock Traders Daily

(TGTX) and the Role of Price-Sensitive Allocations - Stock Traders Daily

Click here to get full coverage on TGTX Forecast — Price Target — Prediction for 2027 - TradingView

TGTX Forecast — Price Target — Prediction for 2027  TradingView

TGTX Forecast — Price Target — Prediction for 2027 - TradingView

Click here to get full coverage on TG Therapeutics (TGTX) Stock May Still Be Cheap Despite New Trial News - Yahoo Finance

TG Therapeutics (TGTX) Stock May Still Be Cheap Despite New Trial News  Yahoo Finance

TG Therapeutics (TGTX) Stock May Still Be Cheap Despite New Trial News - Yahoo Finance

Click here to get full coverage on TG Therapeutics (TGTX) Starts Phase 2 Briumvi Trial - Yahoo Finance

TG Therapeutics (TGTX) Starts Phase 2 Briumvi Trial  Yahoo Finance

TG Therapeutics (TGTX) Starts Phase 2 Briumvi Trial - Yahoo Finance

Click here to get full coverage on Is TG Therapeutics, Inc. (TGTX) A Good Stock To Buy Now? - Yahoo Finance

Is TG Therapeutics, Inc. (TGTX) A Good Stock To Buy Now?  Yahoo Finance

Is TG Therapeutics, Inc. (TGTX) A Good Stock To Buy Now? - Yahoo Finance

Click here to get full coverage on Is TG Therapeutics (TGTX) Fully Valued Following Its Schizophrenia Trial Update? - Yahoo Finance

Is TG Therapeutics (TGTX) Fully Valued Following Its Schizophrenia Trial Update?  Yahoo Finance

Is TG Therapeutics (TGTX) Fully Valued Following Its Schizophrenia Trial Update? - Yahoo Finance

Click here to get full coverage on Can TG Therapeutics' (TGTX) Schizophrenia Trial Meaningfully Redefine BRIUMVI’s Role Beyond Multiple Sclerosis? - Yahoo Finance

Can TG Therapeutics' (TGTX) Schizophrenia Trial Meaningfully Redefine BRIUMVI’s Role Beyond Multiple Sclerosis?  Yahoo Finance

Can TG Therapeutics' (TGTX) Schizophrenia Trial Meaningfully Redefine BRIUMVI’s Role Beyond Multiple Sclerosis? - Yahoo Finance

Click here to get full coverage on TGTX Stock Rises On Wall Street Price Target Hike, New Schizophrenia Trial Launch - Yahoo Finance

TGTX Stock Rises On Wall Street Price Target Hike, New Schizophrenia Trial Launch  Yahoo Finance

TGTX Stock Rises On Wall Street Price Target Hike, New Schizophrenia Trial Launch - Yahoo Finance

Click here to get full coverage on TG Therapeutics (TGTX) Soars 7.5%: Is Further Upside Left in the Stock? - Yahoo Finance

TG Therapeutics (TGTX) Soars 7.5%: Is Further Upside Left in the Stock?  Yahoo Finance

TG Therapeutics (TGTX) Soars 7.5%: Is Further Upside Left in the Stock? - Yahoo Finance

Click here to get full coverage on Will Briumvi's Strength Continue to Aid TGTX's Top Line in Q2? - Yahoo Finance

Will Briumvi's Strength Continue to Aid TGTX's Top Line in Q2?  Yahoo Finance

Will Briumvi's Strength Continue to Aid TGTX's Top Line in Q2? - Yahoo Finance

Click here to get full coverage on TGTX Stock Up on Positive Phase I Data for Subcutaneous Briumvi - Yahoo Finance

TGTX Stock Up on Positive Phase I Data for Subcutaneous Briumvi  Yahoo Finance

TGTX Stock Up on Positive Phase I Data for Subcutaneous Briumvi - Yahoo Finance

Click here to get full coverage on Assessing TG Therapeutics (TGTX) Valuation After Recent Share Price Momentum - Yahoo Finance

Assessing TG Therapeutics (TGTX) Valuation After Recent Share Price Momentum  Yahoo Finance

Assessing TG Therapeutics (TGTX) Valuation After Recent Share Price Momentum - Yahoo Finance

Click here to get full coverage on A Look At TG Therapeutics (TGTX) Valuation After Recent Share Price Momentum - Yahoo Finance

A Look At TG Therapeutics (TGTX) Valuation After Recent Share Price Momentum  Yahoo Finance

A Look At TG Therapeutics (TGTX) Valuation After Recent Share Price Momentum - Yahoo Finance

Click here to get full coverage on Why TG Therapeutics (TGTX) Is Up 27.4% After Raising 2026 Revenue Guidance On BRIUMVI Strength - Yahoo Finance

Why TG Therapeutics (TGTX) Is Up 27.4% After Raising 2026 Revenue Guidance On BRIUMVI Strength  Yahoo Finance

Why TG Therapeutics (TGTX) Is Up 27.4% After Raising 2026 Revenue Guidance On BRIUMVI Strength - Yahoo Finance

Click here to get full coverage on Why Is TG Therapeutics (TGTX) Down 5.7% Since Last Earnings Report? - Yahoo Finance

Why Is TG Therapeutics (TGTX) Down 5.7% Since Last Earnings Report?  Yahoo Finance

Why Is TG Therapeutics (TGTX) Down 5.7% Since Last Earnings Report? - Yahoo Finance

Click here to get full coverage on TGTX Q1 Earnings Miss, Sales Rise Y/Y, Stock Up on Raised 2026 View - Yahoo Finance

TGTX Q1 Earnings Miss, Sales Rise Y/Y, Stock Up on Raised 2026 View  Yahoo Finance

TGTX Q1 Earnings Miss, Sales Rise Y/Y, Stock Up on Raised 2026 View - Yahoo Finance

Click here to get full coverage on TGTX Stock Continues Rally For 8 Straight Sessions On New BRIUMVI Clinical Data - Stocktwits

TGTX Stock Continues Rally For 8 Straight Sessions On New BRIUMVI Clinical Data  Stocktwits

TGTX Stock Continues Rally For 8 Straight Sessions On New BRIUMVI Clinical Data - Stocktwits

Click here to get full coverage on TGTX Rises on Positive Phase I Data for Subcutaneous Briumvi in MG - Yahoo Finance

TGTX Rises on Positive Phase I Data for Subcutaneous Briumvi in MG  Yahoo Finance

TGTX Rises on Positive Phase I Data for Subcutaneous Briumvi in MG - Yahoo Finance

Click here to get full coverage on TG Therapeutics (TGTX) Q1 Earnings Lag Estimates - Yahoo Finance

TG Therapeutics (TGTX) Q1 Earnings Lag Estimates  Yahoo Finance

TG Therapeutics (TGTX) Q1 Earnings Lag Estimates - Yahoo Finance

Click here to get full coverage on Bank of America Securities Keeps Their Sell Rating on TG Therapeutics (TGTX) - The Globe and Mail

Bank of America Securities Keeps Their Sell Rating on TG Therapeutics (TGTX)  The Globe and Mail

Bank of America Securities Keeps Their Sell Rating on TG Therapeutics (TGTX) - The Globe and Mail

Click here to get full coverage on Why TG Therapeutics (TGTX) Is Up 18.4% After Advancing At‑Home Subcutaneous BRIUMVI In MS Treatment - Yahoo Finance

Why TG Therapeutics (TGTX) Is Up 18.4% After Advancing At‑Home Subcutaneous BRIUMVI In MS Treatment  Yahoo Finance

Why TG Therapeutics (TGTX) Is Up 18.4% After Advancing At‑Home Subcutaneous BRIUMVI In MS Treatment - Yahoo Finance

Click here to get full coverage on TG Therapeutics' (NASDAQ:TGTX) Earnings Aren't As Good As They Appear - Yahoo Finance

TG Therapeutics' (NASDAQ:TGTX) Earnings Aren't As Good As They Appear  Yahoo Finance

TG Therapeutics' (NASDAQ:TGTX) Earnings Aren't As Good As They Appear - Yahoo Finance

Click here to get full coverage on A Look At TG Therapeutics (TGTX) Valuation After Recent Positive BRIUMVI Trial Updates - Yahoo Finance

A Look At TG Therapeutics (TGTX) Valuation After Recent Positive BRIUMVI Trial Updates  Yahoo Finance

A Look At TG Therapeutics (TGTX) Valuation After Recent Positive BRIUMVI Trial Updates - Yahoo Finance

Click here to get full coverage on TG Therapeutics Stock 10-Day Winning Spree: Stock Climbs 35% - Trefis

TG Therapeutics Stock 10-Day Winning Spree: Stock Climbs 35%  Trefis

TG Therapeutics Stock 10-Day Winning Spree: Stock Climbs 35% - Trefis

Click here to get full coverage on TGTX Stock Rises 29% in 3 Months: Here's What You Should Know - Yahoo Finance

TGTX Stock Rises 29% in 3 Months: Here's What You Should Know  Yahoo Finance

TGTX Stock Rises 29% in 3 Months: Here's What You Should Know - Yahoo Finance

Click here to get full coverage on A Look At TG Therapeutics (TGTX) Valuation After New US$750 Million Credit Facility - Yahoo Finance

A Look At TG Therapeutics (TGTX) Valuation After New US$750 Million Credit Facility  Yahoo Finance

A Look At TG Therapeutics (TGTX) Valuation After New US$750 Million Credit Facility - Yahoo Finance

Click here to get full coverage on Is TG Therapeutics (TGTX) Pricing Reflecting Its Mixed Multi Year Share Performance? - Yahoo Finance

Is TG Therapeutics (TGTX) Pricing Reflecting Its Mixed Multi Year Share Performance?  Yahoo Finance

Is TG Therapeutics (TGTX) Pricing Reflecting Its Mixed Multi Year Share Performance? - Yahoo Finance

Click here to get full coverage on TG Therapeutics (TGTX) Misses Q4 Earnings Estimates - Yahoo Finance

TG Therapeutics (TGTX) Misses Q4 Earnings Estimates  Yahoo Finance

TG Therapeutics (TGTX) Misses Q4 Earnings Estimates - Yahoo Finance

Click here to get full coverage on BRIUMVI Momentum Leads to Strong Execution for TG Therapeutics (TGTX) - Yahoo Finance

BRIUMVI Momentum Leads to Strong Execution for TG Therapeutics (TGTX)  Yahoo Finance

BRIUMVI Momentum Leads to Strong Execution for TG Therapeutics (TGTX) - Yahoo Finance

Click here to get full coverage on TG Therapeutics Stock Surges 28%, With A 8-Day Winning Spree - Trefis

TG Therapeutics Stock Surges 28%, With A 8-Day Winning Spree  Trefis

TG Therapeutics Stock Surges 28%, With A 8-Day Winning Spree - Trefis

Click here to get full coverage on TGTX Stock Hits Fresh 52-Week High – Here’s Why Retail Is Bullish Despite Q1 Earnings Miss - Stocktwits

TGTX Stock Hits Fresh 52-Week High – Here’s Why Retail Is Bullish Despite Q1 Earnings Miss  Stocktwits

TGTX Stock Hits Fresh 52-Week High – Here’s Why Retail Is Bullish Despite Q1 Earnings Miss - Stocktwits

Click here to get full coverage on TG Therapeutics Inc (NASDAQ:TGTX) Shows Strong Growth and Technical Setup for Potential Upside - ChartMill

TG Therapeutics Inc (NASDAQ:TGTX) Shows Strong Growth and Technical Setup for Potential Upside  ChartMill

TG Therapeutics Inc (NASDAQ:TGTX) Shows Strong Growth and Technical Setup for Potential Upside - ChartMill

Click here to get full coverage on Does TG Therapeutics (NASDAQ:TGTX) Deserve A Spot On Your Watchlist? - Moomoo

Does TG Therapeutics (NASDAQ:TGTX) Deserve A Spot On Your Watchlist?  Moomoo

Does TG Therapeutics (NASDAQ:TGTX) Deserve A Spot On Your Watchlist? - Moomoo

Click here to get full coverage on TG Therapeutics (TGTX) Gains Momentum As The Fair Value Narrative Turns More Cautious - simplywall.st

TG Therapeutics (TGTX) Gains Momentum As The Fair Value Narrative Turns More Cautious  simplywall.st

TG Therapeutics (TGTX) Gains Momentum As The Fair Value Narrative Turns More Cautious - simplywall.st

Click here to get full coverage on TGTX Stock Applies Brakes On 5-Session Losing Streak – Retail Eyes ‘Multi-Billion’ Sales As At-Home Multiple Sclerosis Treatment Gets Boost - Stocktwits

TGTX Stock Applies Brakes On 5-Session Losing Streak – Retail Eyes ‘Multi-Billion’ Sales As At-Home Multiple Sclerosis Treatment Gets Boost  Stocktwits

TGTX Stock Applies Brakes On 5-Session Losing Streak – Retail Eyes ‘Multi-Billion’ Sales As At-Home Multiple Sclerosis Treatment Gets Boost - Stocktwits

Click here to get full coverage on The Utter Rampage That Sent This Biotech Flying 79% - Investor's Business Daily

The Utter Rampage That Sent This Biotech Flying 79%  Investor's Business Daily

The Utter Rampage That Sent This Biotech Flying 79% - Investor's Business Daily

Click here to get full coverage on TG THERAPEUTICS ($TGTX) Releases Q1 2026 Earnings - Quiver Quantitative

TG THERAPEUTICS ($TGTX) Releases Q1 2026 Earnings  Quiver Quantitative

TG THERAPEUTICS ($TGTX) Releases Q1 2026 Earnings - Quiver Quantitative

Click here to get full coverage on TG THERAPEUTICS INC (NASDAQ:TGTX) Q4 2025 Earnings Miss Estimates Despite Strong BRIUMVI Outlook - ChartMill

TG THERAPEUTICS INC (NASDAQ:TGTX) Q4 2025 Earnings Miss Estimates Despite Strong BRIUMVI Outlook  ChartMill

TG THERAPEUTICS INC (NASDAQ:TGTX) Q4 2025 Earnings Miss Estimates Despite Strong BRIUMVI Outlook - ChartMill

Click here to get full coverage on Is BRIUMVI’s Trial in Treatment-Resistant Schizophrenia Altering The Investment Case For TG Therapeutics (TGTX)? - simplywall.st

Is BRIUMVI’s Trial in Treatment-Resistant Schizophrenia Altering The Investment Case For TG Therapeutics (TGTX)?  simplywall.st

Is BRIUMVI’s Trial in Treatment-Resistant Schizophrenia Altering The Investment Case For TG Therapeutics (TGTX)? - simplywall.st

Click here to get full coverage on TG Therapeutics (TGTX) Q1 2026 Earnings Transcript - The Motley Fool

TG Therapeutics (TGTX) Q1 2026 Earnings Transcript  The Motley Fool

TG Therapeutics (TGTX) Q1 2026 Earnings Transcript - The Motley Fool

Click here to get full coverage on TGTX Completes Enrollment in Phase III Study on Subcutaneous Briumvi - Yahoo Finance

TGTX Completes Enrollment in Phase III Study on Subcutaneous Briumvi  Yahoo Finance

TGTX Completes Enrollment in Phase III Study on Subcutaneous Briumvi - Yahoo Finance

Click here to get full coverage on Has The Market Mispriced TG Therapeutics (TGTX) After Recent Biotech Sector Coverage Swings? - simplywall.st

Has The Market Mispriced TG Therapeutics (TGTX) After Recent Biotech Sector Coverage Swings?  simplywall.st

Has The Market Mispriced TG Therapeutics (TGTX) After Recent Biotech Sector Coverage Swings? - simplywall.st

Click here to get full coverage on CEO Michael Weiss joins Goldman Sachs healthcare fireside chat June 9 - Stock Titan

CEO Michael Weiss joins Goldman Sachs healthcare fireside chat June 9  Stock Titan

CEO Michael Weiss joins Goldman Sachs healthcare fireside chat June 9 - Stock Titan

Click here to get full coverage on TG Therapeutics schedules Q1 results call, 2026 outlook for May 6 - Stock Titan

TG Therapeutics schedules Q1 results call, 2026 outlook for May 6  Stock Titan

TG Therapeutics schedules Q1 results call, 2026 outlook for May 6 - Stock Titan

Click here to get full coverage on How Investors Are Reacting To TG Therapeutics (TGTX) Adding Azer-cel Milestone to Its MS Portfolio - Yahoo Finance

How Investors Are Reacting To TG Therapeutics (TGTX) Adding Azer-cel Milestone to Its MS Portfolio  Yahoo Finance

How Investors Are Reacting To TG Therapeutics (TGTX) Adding Azer-cel Milestone to Its MS Portfolio - Yahoo Finance

Click here to get full coverage on TGTX Stock Rallies As BRIUMVI Data And Guidance Impress - StocksToTrade

TGTX Stock Rallies As BRIUMVI Data And Guidance Impress  StocksToTrade

TGTX Stock Rallies As BRIUMVI Data And Guidance Impress - StocksToTrade

Click here to get full coverage on TG Therapeutics, Inc. (TGTX) Stock Analysis: A Biotech Powerhouse with Promising Revenue Growth and Analyst Confidence - DirectorsTalk Interviews

TG Therapeutics, Inc. (TGTX) Stock Analysis: A Biotech Powerhouse with Promising Revenue Growth and Analyst Confidence  DirectorsTalk Interviews

TG Therapeutics, Inc. (TGTX) Stock Analysis: A Biotech Powerhouse with Promising Revenue Growth and Analyst Confidence - DirectorsTalk Interviews

Click here to get full coverage on Multiple Sclerosis-Focused Biotech Quadruples Its Profit, Raises Sales Forecast - Investor's Business Daily

Multiple Sclerosis-Focused Biotech Quadruples Its Profit, Raises Sales Forecast  Investor's Business Daily

Multiple Sclerosis-Focused Biotech Quadruples Its Profit, Raises Sales Forecast - Investor's Business Daily

Click here to get full coverage on Jefferies Maintains TG Therapeutics(TGTX.US) With Buy Rating, Raises Target Price to $83 - Moomoo

Jefferies Maintains TG Therapeutics(TGTX.US) With Buy Rating, Raises Target Price to $83  Moomoo

Jefferies Maintains TG Therapeutics(TGTX.US) With Buy Rating, Raises Target Price to $83 - Moomoo

Click here to get full coverage on TGTX's Single-Dose Briumvi Hits Bioequivalence Goal in MS Study - Yahoo Finance

TGTX's Single-Dose Briumvi Hits Bioequivalence Goal in MS Study  Yahoo Finance

TGTX's Single-Dose Briumvi Hits Bioequivalence Goal in MS Study - Yahoo Finance

Click here to get full coverage on TG THERAPEUTICS INC (NASDAQ:TGTX) Screens as Affordable Growth Play with Strong Revenue Surge and Discounted Valuation - ChartMill

TG THERAPEUTICS INC (NASDAQ:TGTX) Screens as Affordable Growth Play with Strong Revenue Surge and Discounted Valuation  ChartMill

TG THERAPEUTICS INC (NASDAQ:TGTX) Screens as Affordable Growth Play with Strong Revenue Surge and Discounted Valuation - ChartMill

Click here to get full coverage on TG Therapeutics Stock Rises Thursday: What's Driving The Gains? - TG Therapeutics (NASDAQ:TGTX) - Benzinga

TG Therapeutics Stock Rises Thursday: What's Driving The Gains? - TG Therapeutics (NASDAQ:TGTX)  Benzinga

TG Therapeutics Stock Rises Thursday: What's Driving The Gains? - TG Therapeutics (NASDAQ:TGTX) - Benzinga

Click here to get full coverage on (TGTX) Volatility Zones as Tactical Triggers - Stock Traders Daily

(TGTX) Volatility Zones as Tactical Triggers  Stock Traders Daily

(TGTX) Volatility Zones as Tactical Triggers - Stock Traders Daily

Click here to get full coverage on TG Therapeutics (TGTX) Sees Price Target Drop from JPMorgan - Yahoo Finance

TG Therapeutics (TGTX) Sees Price Target Drop from JPMorgan  Yahoo Finance

TG Therapeutics (TGTX) Sees Price Target Drop from JPMorgan - Yahoo Finance

Click here to get full coverage on TG Therapeutics Stock 9-Day Winning Spree: Stock Climbs 33% - Trefis

TG Therapeutics Stock 9-Day Winning Spree: Stock Climbs 33%  Trefis

TG Therapeutics Stock 9-Day Winning Spree: Stock Climbs 33% - Trefis

Click here to get full coverage on TG Therapeutics Stock Surges 35%, With A 10-Day Winning Spree - Trefis

TG Therapeutics Stock Surges 35%, With A 10-Day Winning Spree  Trefis

TG Therapeutics Stock Surges 35%, With A 10-Day Winning Spree - Trefis

Click here to get full coverage on TGTX Maintained by B of A Securities -- Price Target Raised to $20 - GuruFocus

TGTX Maintained by B of A Securities -- Price Target Raised to $20  GuruFocus

TGTX Maintained by B of A Securities -- Price Target Raised to $20 - GuruFocus

Click here to get full coverage on TG Therapeutics tests BRIUMVI in 60 schizophrenia patients - Stock Titan

TG Therapeutics tests BRIUMVI in 60 schizophrenia patients  Stock Titan

TG Therapeutics tests BRIUMVI in 60 schizophrenia patients - Stock Titan

Click here to get full coverage on TG Therapeutics Inc (NASDAQ:TGTX): An Affordable Growth Stock with Strong Momentum - ChartMill

TG Therapeutics Inc (NASDAQ:TGTX): An Affordable Growth Stock with Strong Momentum  ChartMill

TG Therapeutics Inc (NASDAQ:TGTX): An Affordable Growth Stock with Strong Momentum - ChartMill

Click here to get full coverage on TG Therapeutics Stock On Fire: Up 26% With 7-Day Winning Streak - Trefis

TG Therapeutics Stock On Fire: Up 26% With 7-Day Winning Streak  Trefis

TG Therapeutics Stock On Fire: Up 26% With 7-Day Winning Streak - Trefis

Click here to get full coverage on Bank of America Securities Bearish on TG Therapeutics (TGTX) Post Earnings - Yahoo Finance

Bank of America Securities Bearish on TG Therapeutics (TGTX) Post Earnings  Yahoo Finance

Bank of America Securities Bearish on TG Therapeutics (TGTX) Post Earnings - Yahoo Finance

Click here to get full coverage on Assessing TG Therapeutics (TGTX) Valuation After Recent Share Price Weakness And BRIUMVI Growth Assumptions - Yahoo Finance

Assessing TG Therapeutics (TGTX) Valuation After Recent Share Price Weakness And BRIUMVI Growth Assumptions  Yahoo Finance

Assessing TG Therapeutics (TGTX) Valuation After Recent Share Price Weakness And BRIUMVI Growth Assumptions - Yahoo Finance

Click here to get full coverage on TG Therapeutics (TGTX) Q1 2026 Results Put 66% Net Margin Narrative To The Test - simplywall.st

TG Therapeutics (TGTX) Q1 2026 Results Put 66% Net Margin Narrative To The Test  simplywall.st

TG Therapeutics (TGTX) Q1 2026 Results Put 66% Net Margin Narrative To The Test - simplywall.st

Click here to get full coverage on TGTX Stock Strengthens As Briumvi Momentum And Guidance Rise - StocksToTrade

TGTX Stock Strengthens As Briumvi Momentum And Guidance Rise  StocksToTrade

TGTX

Price Chart

Key Statistics

Technicals

About TGTX

Latest News

TG Therapeutics (TGTX) Gains as Its Key Drug Exceeded Expectations - Yahoo Finance

Is TG Therapeutics (TGTX) Fully Valued Following Its New Schizophrenia Trial Launch? - simplywall.st

TGTX Maintained by HC Wainwright & Co. -- Price Target Raised to $77 - GuruFocus

Advanced Charts

Top Gainers

Top Losers